IVCC

Registered charity 1128437 · accounts filings on the Charity Commission register

The IVCC is a Product Development Partnership (PDP) established as a not for profit company and registered charity to overcome the barriers to innovation in the development of new insecticides for public health vector control and to develop information systems and tools which will enable new and existing pesticides to be used more effectively.

Causes: The Advancement Of Health Or Saving Of Lives · Economic/community Development/employment · Grant history (this charity is a funder) · website · Get email alerts

Latest income
£19.1m
Latest spending
£17.3m
Registered
2009
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity generated a surplus of £1.8m for the year ended 31 July 2025, resulting in total free/unrestricted reserves of £13.0m. The trustees confirm that the charity has adequate resources to continue in operation for the foreseeable future, citing a positive bank balance of £9.1m and significant deferred income. The financial position is supported by a strong asset base and medium-term funding visibility from major donors.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Largest income source: FCDO (54% of income)
“FCDO accounted for 54% of the charity’s income in the year, up from 33% in 2024.” — page 12
Per its FY2025 accounts as filed with the Charity Commission.
Reserves policy: minimum of 6 months' pay expenditure (£1.6m) (held: £13.0m)
“IVCC aligns with the group policy of ensuring that unrestricted reserves represent a minimum of 6 months' pay expenditure (£1.6m).” — page 13
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Grants passed to parent company
“During 2025, charitable research grants totalling £1,899,000 (2024: £2,180,000) were passed to IVCC’s parent company Liverpool School of Tropical Medicine (LSTM); all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £3,444,000 (2024: £1,218,000) were passed to IVCC’s sister company iiDiagnostics ; all had performance conditions attached.” — page 31
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Grants passed to sister company
“During 2025, charitable research grants totalling £1,899,000 (2024: £2,180,000) were passed to IVCC’s parent company Liverpool School of Tropical Medicine (LSTM); all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £3,444,000 (2024: £1,218,000) were passed to IVCC’s sister company iiDiagnostics ; all had performance conditions attached.” — page 31
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Outstanding creditor to parent company
“During 2025, charitable research grants totalling £1,899,000 (2024: £2,180,000) were passed to IVCC’s parent company Liverpool School of Tropical Medicine (LSTM); all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £3,444,000 (2024: £1,218,000) were passed to IVCC’s sister company iiDiagnostics ; all had performance conditions attached.” — page 31
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Outstanding creditor to sister company
“During 2025, charitable research grants totalling £1,899,000 (2024: £2,180,000) were passed to IVCC’s parent company Liverpool School of Tropical Medicine (LSTM); all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £3,444,000 (2024: £1,218,000) were passed to IVCC’s sister company iiDiagnostics ; all had performance conditions attached.” — page 31
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Rental charges to sister company
“During 2025, charitable research grants totalling £1,899,000 (2024: £2,180,000) were passed to IVCC’s parent company Liverpool School of Tropical Medicine (LSTM); all had performance conditions attached.” — page 31
“During 2025, charitable research grants totalling £3,444,000 (2024: £1,218,000) were passed to IVCC’s sister company iiDiagnostics ; all had performance conditions attached.” — page 31
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by Crowe U.K. LLP. Discloses 4 of 6 completeness components.

Leadership, per the charity’s website

Listed on the charity’s own website when we last crawled it; roles may have changed. Pay-band disclosures above are anonymous statutory disclosures and are not attributed to any named individual.

Funders the charity credits

Named as funders/supporters on the charity’s own website (the charity’s claim, distinct from accounts-verified grants).

Structured financials (annual return, FY ending 31/07/2025)

Total income
£19.1m
Total spending
£17.3m
Reserves (reported)
£13.0m
Employees
25

Reported reserves equal ~9.1 months of spending — above the median for charities its size (median 4.6 months; benchmarks).

Per its annual return, largest income source: Charitable activities (97% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 0.0% of total income — below the median for charities its size (3.8%) (benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Australia · Benin · Burkina Faso · Camden · Canada · China · Denmark · France · Germany · Ghana · Greece · Ireland

Income and spending

Financial year endIncomeSpending
31/07/2025£19.1m£17.3m
31/07/2024£20.3m£20.2m
31/07/2023£33.4m£32.3m
31/07/2022£48.6m£47.5m
31/07/2021£39.4m£38.2m

Common questions

Is IVCC financially healthy?

Per its FY2025 accounts: The accounts state that the charity generated a surplus of £1.8m for the year ended 31 July 2025, resulting in total free/unrestricted reserves of £13.0m. The trustees confirm that the charity has adequate resources to continue in operation for the foreseeable future, citing a positive bank balance of £9.1m and significant deferred income. The financial position is supported by a strong asset base and medium-term funding visibility from major donors. Its FY2025 accounts were audited by Crowe U.K. LLP.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with INSTITUTE FOR VOLUNTARY ACTION RESEARCH.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
IVCC£19.1m——unclear—no doubt
INSTITUTE FOR VOLUNTARY ACTION RESEARCH FY2025£1.0m——unclear—no doubt
THE INTERNATIONAL INSTITUTE FOR CONSERVATION OF HISTORIC AND ARTISTIC WORKS FY2025£435k£60,000 - £69,0001above—no doubt
INFECTION PREVENTION SOCIETY FY2025£825k—0above—no doubt
THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY FY2025£433k£70,001 - £80,0001unclear6.0%no doubt
INSTITUTE OF HEALTH VISITING FY2025£1.7m£70,001 - £80,0002unclear—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.